Investigator
Jing Yang
UNIVERSITY OF CALIFORNIA, SAN DIEGO · funded by NCI, NIEHS, NHLBI
- Companies
- 2
- Grants
- 12
- Non-dilutive funding
- $5.7M
- First award
- Mar 1, 1993
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Aug 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE91momentum
OncologyGrant-only
- APLEXIS, INC.81momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$437kAug 1, 2025NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11334587 (opens the source filing in a new tab)
- R01
Cytoplasmic remodeling during the vertebrate oocyte-to-embryo transition
$627kJan 24, 2025NIEHSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11049710 (opens the source filing in a new tab)
- R01
Cytoplasmic remodeling during the vertebrate oocyte-to-embryo transition
$613kJan 24, 2025NIEHSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11262885 (opens the source filing in a new tab)
- R44
Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
$1.1MSep 15, 2022NHLBIAPLEXIS, INC.NIH RePORTER · 11051837 (opens the source filing in a new tab)
- R01
Functional interplay between Hippo and estrogen receptor ESR1
$434kMar 1, 2022NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11042246 (opens the source filing in a new tab)
- R01
Functional interplay between Hippo and estrogen receptor ESR1
$434kMar 1, 2022NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11296882 (opens the source filing in a new tab)
- R35
Intracellular Remodeling during Early Development
$476kJul 1, 2019NIGMSUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGNNIH RePORTER · 11252306 (opens the source filing in a new tab)
- R01
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$364kAug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11006267 (opens the source filing in a new tab)
- R01
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$51kAug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11378902 (opens the source filing in a new tab)
- R01
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$364kAug 1, 2015NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11264836 (opens the source filing in a new tab)
- P30
Cancer Biology and Signaling Program
$90kJul 1, 1996NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11335311 (opens the source filing in a new tab)
- T32
Contemporary Approaches to Cancer Cell Signaling and Communication
$674kMar 1, 1993NCIUNIVERSITY OF CALIFORNIA, SAN DIEGONIH RePORTER · 11099666 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources